The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Creative Commons License

Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W. , Bartunek J., KILIÇ T. , ...More

EUROINTERVENTION, vol.15, no.5, pp.403-410, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.4244/eij-d-19-00342
  • Title of Journal : EUROINTERVENTION
  • Page Numbers: pp.403-410


Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.